ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Oncology Institute Inc

Oncology Institute Inc (TOI)

0.4557
-0.0083
( -1.79% )
Updated: 11:13:50

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.4557
Bid
0.4515
Ask
0.4597
Volume
71,047
0.451 Day's Range 0.5374
0.426 52 Week Range 2.655
Market Cap
Previous Close
0.464
Open
0.475
Last Trade
23
@
0.4597
Last Trade Time
11:16:43
Financial Volume
$ 33,782
VWAP
0.475495
Average Volume (3m)
187,272
Shares Outstanding
73,748,979
Dividend Yield
-
PE Ratio
-9.75
Earnings Per Share (EPS)
-1.13
Revenue
324.24M
Net Profit
-83.07M

About Oncology Institute Inc

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counsel... The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Show more

Sector
Offices Of Medical Doctors
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
2021
Oncology Institute Inc is listed in the Offices Of Medical Doctors sector of the NASDAQ with ticker TOI. The last closing price for Oncology Institute was $0.46. Over the last year, Oncology Institute shares have traded in a share price range of $ 0.426 to $ 2.655.

Oncology Institute currently has 73,748,979 shares outstanding. The market capitalization of Oncology Institute is $809.76 million. Oncology Institute has a price to earnings ratio (PE ratio) of -9.75.

TOI Latest News

The Oncology Institute to Participate at Upcoming Investor Conferences

CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel...

The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference

CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives’ participation in multiple panel...

The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance

CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel...

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that...

Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute

CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief...

The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California

CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 primary care...

The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024

CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01473.333333333330.4410.5490.4261569190.47740997CS
4-0.2302-33.56174369440.68590.6970.4262611270.51419005CS
12-0.9243-66.97826086961.381.890.4261872720.85633963CS
26-0.7043-60.71551724141.162.50.4261745621.34788243CS
52-0.0346-7.056903936370.49032.6550.4262555491.25770875CS
156-9.4043-95.3782961469.8612.660.332398792.06149801CS
260-9.4043-95.3782961469.8612.660.332398792.06149801CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.22
(283.82%)
40.69M
SVMHSRIVARU Holding Ltd
$ 0.318
(108.52%)
204.79M
TOIIWOncology Institute Inc
$ 0.032
(75.82%)
58.62k
CNSPCNS Pharmaceuticals Inc
$ 5.915
(63.40%)
4.62M
ARECAmerican Resources Corporation
$ 1.07
(44.59%)
2.99M
GANXGain Therapeutics Inc
$ 1.2798
(-32.29%)
1.9M
NXLNexalin Technologies Inc
$ 0.9389
(-31.98%)
2.7M
INABIN8bio Inc
$ 1.1704
(-30.33%)
2.46M
KYTXKyverna Therapeutics Inc
$ 10.40
(-27.98%)
2M
QXOQXO Inc
$ 148.9154
(-27.50%)
98.14k
SVMHSRIVARU Holding Ltd
$ 0.318
(108.52%)
204.79M
NVDANVIDIA Corporation
$ 131.34
(1.33%)
130.78M
LGVNLongeveron Inc
$ 3.7199
(38.29%)
71.18M
KITTNauticus Robotics Inc
$ 0.22
(37.07%)
58.16M
SQQQProShares UltraPro Short QQQ
$ 8.5097
(-0.35%)
47.98M

TOI Discussion

View Posts
boston127 boston127 7 months ago
Thanks. I like it.

I may approach them about reselling my company's product.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
MREO MY FAV BIO
👍️0
boston127 boston127 7 months ago
I did. Where do you recommend next?

Is this going to be a better play soon? I am in heavy, and in the red, with LGHL. would appreciate a quick look and feedback on that board, not here. TOI has so many good things going for it - owned by institutions - it is going to be hard for me not to eventually get in here.
👍️0
boywonder1 boywonder1 7 months ago
The chart has contradictions like yourself and you're posting history ‼️‼️2😂
👍️ 1 💯 1
TrendTrade2016 TrendTrade2016 7 months ago
Glad you listened
💩 1 🤡 1
boston127 boston127 7 months ago
You were correct. Took a major haircut.

Glad I did not jump in. Thanks. What do you like?
👍️0
boston127 boston127 7 months ago
The Warrants do not expire

until November, 2026. I may start adding them. I can get 10 Ws for every 1 Common.
👍️0
boston127 boston127 7 months ago
What important indicators?

TOI appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
As of 3:00 PM ET Friday, 11/03/2023
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
important indicators going down as stock is going up...red flag!!!!
👍️0
boston127 boston127 7 months ago
Can you explain?

Do you know anything about the warrants? Strike price, expiration date, etc.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CHART HAS SOME CONTRADICTIONS
💩 1 🤡 1
boston127 boston127 7 months ago
It sure is acting perky.

Nice move AH and Premarket. I'm going to jump in today if the move north continues.
👍️0
boston127 boston127 9 months ago
Common goes down.

Warrants go up on very light volume. Hard to figure.
👍️0
hedge_fun hedge_fun 9 months ago
She was under 40 cents in mid June……

I would say she’s is already flying.

Been my best play this year.
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
TOI...READY TO FLY
💩 1 🤡 1
TrendTrade2016 TrendTrade2016 9 months ago
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
MONSTER IN DA MAKING
👍️0
hedge_fun hedge_fun 9 months ago
It’s tripled since mid-June…..
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
MONSTER PLAY HERE....
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
TOI BEAUTY BOTTOM HERE ...AI CANCER PLAY
👍️0
hedge_fun hedge_fun 9 months ago
Company repurchasing more shares. Nice…..
👍️0
hedge_fun hedge_fun 10 months ago
August starting out like July…….
👍️0
hedge_fun hedge_fun 11 months ago
On watch. Thx
👍️0
CaptPete1776 CaptPete1776 11 months ago
Keep eye in $Getr over .55. That’s the breakout spot could explode over .70. I’ve been swinging this also.
👍️0
CaptPete1776 CaptPete1776 11 months ago
I have some left yes just don’t want to get to greedy
👍️0
hedge_fun hedge_fun 11 months ago
I hope you’re still holding some. I’m enjoying the ride.
👍️0
CaptPete1776 CaptPete1776 11 months ago
Looks great. I sold some here .89
👍️0
hedge_fun hedge_fun 11 months ago
I don’t want July to end!!!
👍️0
CaptPete1776 CaptPete1776 11 months ago
Holding in today's nasdaq slide and up on the day. .90 is coming next
👍️0
CaptPete1776 CaptPete1776 11 months ago
Yes definitely
👍️0
hedge_fun hedge_fun 11 months ago
Been a nice move the past 2 weeks……
👍️0
hedge_fun hedge_fun 12 months ago
The low volume dips with 100 share trades……

are fishy.

Maybe this proves to be support.

Long term hold for me.
👍️0
CaptPete1776 CaptPete1776 12 months ago
Let’s get more good new out. It’s been holding strong since the last news about stock repurchase plan.
👍️0
hedge_fun hedge_fun 12 months ago
On June 14, 2023, the Board of Directors of The Oncology Institute, Inc. (the “Company”) approved a share repurchase program with authorization to purchase up to 5 million shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The Company may repurchase shares from time to time through one or more securities broker-dealers, in open market purchases and negotiated purchases, in each case at price per share not to exceed $0.75. Shares repurchased by the Company pursuant to the share repurchase program shall be returned to the status of authorized but unissued shares of Common Stock.

In connection with the foregoing, on June 14, 2023, the Company entered into a limited consent (the “Limited Consent”), dated as of June 14, 2023, to that certain Facility Agreement, dated as of August 9, 2022 (the “Facility Agreement”), by and among the Company, as borrower, certain of the Company’s subsidiaries from time to time party thereto as guarantors and Deerfield Partners, L.P., as agent for itself and the lenders (collectively, “Deerfield”). The Limited Consent permits the repurchase by the Company on or prior to June 16, 2023, of up to 5,000,000 shares of the Company’s Common Stock in one or more open market or negotiated purchases, in each case at price per share not to exceed $0.75. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors. The Limited Consent does not obligate the Company to repurchase any amount of shares, and there can be no assurance that any shares will be repurchased. The Limited Consent also grants a one-time waiver under the Facility Agreement of certain delivery of any notice requirements.

The foregoing description of the Limited Consent does not purport to be complete and is qualified in its entirety by reference to the full text of the Limited Consent, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
👍️0

Your Recent History

Delayed Upgrade Clock